Application of Navi plate and hInGetox technologies to iPSc derived human T cells to assay CAR-T cell tumorigenic potential
Funder: National Centre for the Replacement, Refinement and Reduction of Animals in ResearchDuration: January 2025 - June 2025
Grant for gene therapy safety
People
| Name | Telephone | Office | ||
|---|---|---|---|---|
|
Professor Michael Themis Professor - Gene Therapy and Genotoxicity (Principal investigator)
T: +44 (0)1895 267252
E: michael.themis@brunel.ac.uk |
+44 (0)1895 267252 | michael.themis@brunel.ac.uk | Heinz Wolff 235 |